Ambrx Biopharma Inc. (AMAM) has a market capitalization of $1.77B and trades at $28.00. The 52-week range is 6.55-28.15.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -13.9, Earnings Per Share (EPS) of $-2.02, annual revenue of $7.4M.
The stock has a beta of -2.36, operates in the Healthcare sector.
